The Shanmuga Hospital IPO listing gain is 0% on BSE, stock opened at ₹54. The Shanmuga Hospital IPO was subscribed 2.51 times, receiving 90.88 lakh bids for 36.26 lakh shares. The Market Maker category was fully subscribed at 1x, while Non-Institutional Buyers subscribed 0.6x (10.94 lakh shares). Retail Investors showed strong demand, subscribing 4.41x (79.94 lakh shares). The IPO received 6,563 applications, with total bids worth ₹49.08 crore.
Shanmuga Hospital IPO listed at ₹54 on the BSE, reflecting a 0% listing gain. The last recorded GMP (Grey Market Premium) was ₹3, suggesting an expected listing price of ₹57. However, the actual listing fell short of GMP expectations by ₹3, indicating weaker-than-anticipated demand.
Overview of Contents
Details About Shanmuga Hospital IPO
Shanmuga Hospital’s Fixed Price IPO aims to raise ₹20.62 crore through a fresh issue of 38.18 lakh shares at ₹54 per share. The IPO has a 50% retail quota and a 50% HNI quota, while QIB details are yet to be updated. The company has demonstrated steady financial growth, with revenue rising to ₹43.39 crore in 2024 from ₹39.5 crore in 2023, and net profit increasing to ₹5.26 crore from ₹4.76 crore.
- Retail Investors: Minimum lot size of 2,000 shares, requiring an investment of ₹1,08,000.
- HNIs: Must apply for at least 2 lots (4,000 shares), amounting to ₹2,16,000.
Shanmuga Hospital IPO Funds Deployment
- Capital Expenditure: Purchase of additional medical equipment.
- General Corporate Purposes: Remaining funds allocated for business needs.
Shanmuga Hospital IPO Financial Performance
Shanmuga Hospital has shown steady financial growth, with revenue reaching ₹43.39 crore in FY24, up from ₹39.5 crore in FY23. Profit After Tax rose to ₹5.26 crore from ₹4.76 crore. Total assets increased to ₹36.53 crore as of September 2024, while net worth grew to ₹19.53 crore. Reserves stood at ₹9.73 crore, and total borrowings rose to ₹9.76 crore from ₹7.65 crore in FY23.